10/09/2012 - 7:13am

A meeting with federal officials last week indicates that pharmacists' importance in dispensing animal drugs is growing.

10/08/2012 - 1:31pm

A pharmacy school in Alabama is getting a grant for a program designed to reduce hospitalizations among nursing home residents.

10/08/2012 - 10:15am

European regulators have approved U.S. drug maker Watson's acquisition of Switzerland-based Actavis, Watson said.

10/05/2012 - 12:11pm

The National Community Pharmacists Association on Thursday commended a bipartisan group of 13 U.S. representatives for a letter they jointly sent to the Drug Enforcement Administration requesting “clarification, guidance and collaboration,” and suggesting that the federal agency’s efforts in addressing supply chain issues of controlled substances across Florida-based distribution centers and pharmacies may be inadvertently preventing patients from accessing certain prescription drugs for which they have legitimate medical needs and prescriptions.

10/05/2012 - 11:32am

The Food and Drug Administration has reviewed new data that indicated that budeprion XL (bupropion hydrochloride extended-release tablets) in the 300-mg strength, manufactured by Impax Labs and Teva Pharmaceuticals USA, is not therapeutically equivalent to Wellbutrin XL in the 300-mg strength.

10/05/2012 - 11:15am

In partnership with international regulatory and law enforcement agencies, the Food and Drug Administration on Thursday announced it had taken action against more than 4,100 Internet pharmacies that illegally sell unapproved drugs to consumers.

10/02/2012 - 12:02pm

Drug makers Takeda Pharmaceutical and H. Lundbeck have applied with the Food and Drug Administration for a new drug to treat depression in adults.

10/01/2012 - 3:27pm

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association are mobilizing communities to stop prescription and over-the-counter medicine abuse during National Medicine Abuse Awareness Month, the groups announced Monday.

10/01/2012 - 11:00am

Rep. Mike Honda, D-Calif., of the Silicon Valley is preparing to introduce legislation that will create a new division within the Food and Drug Administration to govern fast-developing healthcare applications, according to a report published by Kaiser Health News last week.